You are now leaving the Lundbeck Canada website
Links to sites outside of Lundbeck Canada are provided as resources to visitors and may not reflect Canada regulation or prescribing information. Lundbeck Canada accepts no responsibility for the content of linked sites.
Our Products in Canada
Names and Compounds of our Products
| Disease Area | Trademark | Compound | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Other | ᴾᴿAbilify Maintena® | Aripiprazole | |||||||
Downloads |
|||||||||
| ᴾᴿCelexa® | citalopram hydrobromide | ||||||||
Downloads |
|||||||||
| ᴾᴿCipralex® | escitalopram oxalate | ||||||||
Downloads |
|||||||||
| ᴾᴿCLOPIXOL® | Zuclopenthixol (as hydrochloride) | ||||||||
Downloads |
|||||||||
| ᴾᴿClopixol-Acuphase® | Zuclopenthixol (as acetate) | ||||||||
Downloads |
|||||||||
| ᴾᴿClopixol®Depot | Zuclopenthixol (as decanoate) | ||||||||
Downloads |
|||||||||
| ᴾᴿEbixa® | memantine hydrochloride | ||||||||
Downloads |
|||||||||
| ᴾᴿFluanxol® | Flupentixol (as dihydrochloride) | ||||||||
Downloads |
|||||||||
| ᴾᴿFluanxol®Depot | Flupentixol (as decanoate) | ||||||||
Downloads |
|||||||||
| ᴾᴿRexulti® | brexpiprazole | ||||||||
Downloads |
|||||||||
| ᴾᴿSabril® | vigabatrin | ||||||||
Downloads |
|||||||||
| ᴾᴿTrintellix® | vortioxetine hydrobromide | ||||||||
Downloads |
|||||||||
| ᴾᴿVyepti® | Eptinezumab | ||||||||
Downloads |
|||||||||
Federal regulations limit the scope of information that pharmaceutical companies are authorized to give on prescription drugs via the internet or other means. To obtain more detailed information on the properties or appropriate use of any prescription drug, please consult a qualified health care professional. The products discussed herein may have different product labeling in different countries. The product information on this site is intended only for residents of Canada.
Ebixa® is a registered trademark of Merz Pharma GmbH, used under license by Lundbeck Canada Inc.
Abilify Maintena® and Rexulti® are registered trademarks of Otsuka Pharmaceutical Co., Ltd, marketed by Otsuka Canada Pharmaceutical Inc., and Lundbeck Canada Inc.
Sabril® is a Lundbeck LLC product, used under license by Lundbeck Canada Inc.. For medical information regarding this product, please visit the Lundbeck US Product site.
Vyepti® is a registered trademark of H. Lundbeck A/S, used under license by Lundbeck Canada Inc.
More from lundbeck
R&D of new and improved treatments is at the core of what we do.
We are singularly focused on advancing therapies for brain diseases.
Discover our projects and compounds in development.